The pharmaceutical sector in India presents a challenging landscape, increasingly marked by concerns surrounding dominance . While the nation boasts a vibrant generic sector , a few large companies maintain a disproportionate portion of the sales, raising questions about competition and consumer access to affordable drugs . This scenario is fueled

The global pharmaceutical industry is dominated by a handful of large corporations that exert considerable influence over drug prices and availability. These major players control vast research and development|R&D|clinical trials budgets, allowing them to compete effectively in the development of new medications. The result is often high treatment